Evidence map›Paper›PMID 37338350›Full record

ArticleJournal of virology2023

SLF2 Interacts with the SMC5/6 Complex to Direct Hepatitis B Virus Episomal DNA to Promyelocytic Leukemia Bodies for Transcriptional Repression.

Qiyan Yao, Bo Peng, Cong Li, Xuelei Li, Mingyi Chen, Zhongmin Zhou, Dingbin Tang, Jiabei He, Yumeng Wu, Yinyan Sun and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Qiyan YaoGraduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
Bo PengNational Institute of Biological Sciences, Beijing, China.
Cong LiNational Institute of Biological Sciences, Beijing, China.
Xuelei LiNational Institute of Biological Sciences, Beijing, China.
Mingyi ChenNational Institute of Biological Sciences, Beijing, China.
Zhongmin ZhouNational Institute of Biological Sciences, Beijing, China.
Dingbin TangNational Institute of Biological Sciences, Beijing, China.
Jiabei HeNational Institute of Biological Sciences, Beijing, China.
Yumeng WuNational Institute of Biological Sciences, Beijing, China.
Yinyan SunNational Institute of Biological Sciences, Beijing, China.
Wenhui LiNational Institute of Biological Sciences, Beijing, China.ORCID 0000-0003-1305-7404
National Institute of Biological Sciences, Beijing · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis B virus (HBV) chronically infects approximately 300 million people worldwide, and permanently repressing transcription of covalently closed circular DNA (cccDNA), the episomal viral DNA reservoir, is an attractive approach toward curing HBV. However, the mechanism underlying cccDNA transcription is only partially understood. In this study, by illuminating cccDNA of wild-type HBV (HBV-WT) and transcriptionally inactive HBV that bears a deficient HBV X gene (HBV-ΔX), we found that the HBV-ΔX cccDNA more frequently colocalizes with promyelocytic leukemia (PML) bodies than that of HBV-WT cccDNA. A small interfering RNA (siRNA) screen targeting 91 PML body-related proteins identified SMC5-SMC6 localization factor 2 (SLF2) as a host restriction factor of cccDNA transcription, and subsequent studies showed that SLF2 mediates HBV cccDNA entrapment in PML bodies by interacting with the SMC5/6 complex. We further showed that the region of SLF2 comprising residues 590 to 710 interacts with and recruits the SMC5/6 complex to PML bodies, and the C-terminal domain of SLF2 containing this region is necessary for repression of cccDNA transcription. Our findings shed new light on cellular mechanisms that inhibit HBV infection and lend further support for targeting the HBx pathway to repress HBV activity.

Indexed as

Hepatitis BLeukemiaAntiviral AgentsCell Cycle ProteinsChromosomal Proteins, Non-HistoneDNA, CircularDNA, ViralHepatitis B virusHumansPromyelocytic Leukemia ProteinVirus ReplicationAntiviral AgentsCell Cycle ProteinsChromosomal Proteins, Non-HistoneDNA, CircularDNA, ViralPromyelocytic Leukemia ProteinSMC5 protein, humancccDNAhepatitis B virusPML bodiesSLF2SMC5/6 complex

Identifiers

PMID37338350
PMCPMC10373549
OpenAlexW4381248102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.